Readable research linked to original sources
Articles
Browse normalized, publication-ready research with direct links to its evidence and source.
Loading articles data…
Readable research linked to original sources
Browse normalized, publication-ready research with direct links to its evidence and source.
Loading articles data…
Readable research linked to original sources
Browse normalized, publication-ready research with direct links to its evidence and source.
10 articles
Newest firstBACKGROUND: The United Kingdom legalized medical cannabis in 2018, yet little is known about people using cannabis medically with and without a prescription. This study aimed to estimate: 1) the percentage of people reporting using cannabis medically with and without a prescription; 2) the sources; 3) products used; and 4) associations between frequent product use and medical cannabis status. METHODS: Data were fr…
Open article record in new tab ↗Since federal legalisation in November 2016, Australia’s medical cannabis regulation has evolved into a complex framework that involves the Therapeutic Goods Administration, state health departments, and multiple professional oversight bodies. This narrative review examines the policy hurdles and coordination gaps that have emerged between 2016 and 2024, providing a longitudinal perspective on the ongoing debate.…
Open article record in new tab ↗ObjectiveTo comprehensively identify the multi-level barriers to tuberculosis prevention and care in high-burden settings, and prioritize them according to their perceived harm and modifiability. MethodsWe conducted a multi-phase stakeholder-engaged study, synthesized barriers from two scoping reviews, and then convened regional workshops in Hyderabad, India, and Nairobi, Kenya, prioritizing TB survivors, communit…
Open article record in new tab ↗AO_SCPLOWBSTRACTC_SCPLOWO_ST_ABSBackgroundC_ST_ABSEnsuring appropriate access to essential antibiotics is a critical global public health goal. The UN General Assembly agreed that 70% of global antibiotic use should be WHO Access group. A standard method to estimate optimal antibiotic use based on burden of disease, resistance and local context is needed to inform national policies. MethodsUsing data from multiple…
Open article record in new tab ↗Background and AimsThe UK legalised medical cannabis in 2018, yet little is known about people accessing cannabis legally via prescription or those using cannabis for medical purposes without a prescription. This study aimed to estimate: 1) the percentage of people who use cannabis medically with and without a prescription; 2) the sources used to obtain cannabis; 3) the products used; and 4) the associations betwe…
Open article record in new tab ↗Objective Where a person lives is a recognized socioeconomic determinant of health and influences healthcare access. This study aimed to compare the pain treatment profile of persons with chronic pain (CP) living in remote regions to those living in non-remote regions (near or in major urban centers). Methods A cross-sectional study was performed among persons living with CP across Quebec. In a web-based questionn…
The global population is undergoing a significant surge in aging leading to increased susceptibility to various forms of progressive illnesses. This phenomenon significantly impacts both individual health and healthcare systems. Low and Middle Income Countries face particular challenges, as their Primary Health Care (PHC) settings often lack the necessary human and material resources to effectively address the esc…
Open article record in new tab ↗Background Since 2001, Canadians have been able to obtain cannabis for medical purposes, initially through the Access to Cannabis for Medical Purposes Regulations (ACMPR). The Cannabis Act (Bill C-45) came into force on October 17, 2018, replacing the ACMPR. The Cannabis Act enables Canadians to possess cannabis purchased from a licensed retailer without authorization for either medical or nonmedical purposes. The…
Open article record in new tab ↗ObjectivesHIV Pre-Exposure Prophylaxis (PrEP) is a highly effective biomedical intervention for HIV prevention and is key to HIV transmission elimination. However, implementation is challenging. We identified barriers and facilitators to PrEP awareness and access during the roll out of Scotlands national PrEP programme to develop recommendations for future provision. DesignMulti-perspectival qualitative approach i…
BackgroundUpper middle income countries have made substantial progress towards universal health coverage. We investigated whether the coverage extended to diseases that incur catastrophic health spending, the contribution of pooled financing and the factors driving it in Malaysia.\n\nMethodsWe adapted the WHO definition of catastrophic health spending to define costly treatment as one that cost, at prevailing mark…